Use of contemporary cardiometabolic therapies in cardiac amyloidosis treated with tafamidis: A real-world propensity-matched analysis. // Archives of Cardiovascular Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1875213626003475?dgcid=rss_sd_all
Use of contemporary cardiometabolic therapies in cardiac amyloidosis treated with tafamidis: A real-world propensity-matched analysis. Archives of Cardiovascular Diseases. https://www.sciencedirect.com/science/article/pii/S1875213626003475?dgcid=rss_sd_all
“Use of contemporary cardiometabolic therapies in cardiac amyloidosis treated with tafamidis: A real-world propensity-matched analysis.” Archives of Cardiovascular Diseases.
@article{article36382,
title = {Use of contemporary cardiometabolic therapies in cardiac amyloidosis treated with tafamidis: A real-world propensity-matched analysis},
journal = {Archives of Cardiovascular Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1875213626003475?dgcid=rss_sd_all}
}